vimarsana.com
Home
Live Updates
Crohns Patients Respond to Stelara, Results From Phase 3 Trial Show : vimarsana.com
Crohn's Patients Respond to Stelara, Results From Phase 3 Trial Show
Stelara treatment for severely active Crohn's disease resulted in high clinical response and clinical remission rates, according to 16-week trial results.
Related Keywords
Milan ,
Lombardia ,
Italy ,
Silvio Danese ,
Jan Wehkamp ,
Janssen Pharmaceuticals ,
European Crohn Colitis Organization ,
Janssen Research Development ,
Johnson ,
European Crohn ,
Colitis Organization ,
Disease Activity Index ,
Inflammatory Bowel Diseases Center ,
Humanitas Research Hospital ,
Janssen Research ,
vimarsana.com © 2020. All Rights Reserved.